Department of Chemistry, The Scripps Research Institute, Jupiter, FL 33458, United States; Department of Chemistry, University at Buffalo, Buffalo, NY 14620, United States.
Bioorg Med Chem. 2013 Oct 15;21(20):6132-8. doi: 10.1016/j.bmc.2013.04.072. Epub 2013 May 7.
RNA is an extremely important target for the development of chemical probes of function or small molecule therapeutics. Aminoglycosides are the most well studied class of small molecules to target RNA. However, the RNA motifs outside of the bacterial rRNA A-site that are likely to be bound by these compounds in biological systems is largely unknown. If such information were known, it could allow for aminoglycosides to be exploited to target other RNAs and, in addition, could provide invaluable insights into potential bystander targets of these clinically used drugs. We utilized two-dimensional combinatorial screening (2DCS), a library-versus-library screening approach, to select the motifs displayed in a 3×3 nucleotide internal loop library and in a 6-nucleotide hairpin library that bind with high affinity and selectivity to six aminoglycoside derivatives. The selected RNA motifs were then analyzed using structure-activity relationships through sequencing (StARTS), a statistical approach that defines the privileged RNA motif space that binds a small molecule. StARTS allowed for the facile annotation of the selected RNA motif-aminoglycoside interactions in terms of affinity and selectivity. The interactions selected by 2DCS generally have nanomolar affinities, which is higher affinity than the binding of aminoglycosides to a mimic of their therapeutic target, the bacterial rRNA A-site.
RNA 是化学探针功能或小分子治疗药物开发的一个极其重要的靶点。氨基糖苷类是研究最多的靶向 RNA 的小分子类药物。然而,在生物系统中,这些化合物可能结合的、位于细菌 rRNA A 位之外的 RNA 基序在很大程度上是未知的。如果这些信息被了解,那么氨基糖苷类药物就可以被用来靶向其他 RNA,此外,还可以为这些临床应用药物的潜在旁观者靶点提供宝贵的见解。我们利用二维组合筛选(2DCS),一种库对库筛选方法,从一个 3×3 核苷酸内环库和一个 6 核苷酸发夹库中选择与六个氨基糖苷衍生物高亲和力和选择性结合的基序。然后,通过序列测定(StARTS),一种定义结合小分子的特权 RNA 基序空间的统计方法,对所选 RNA 基序进行结构-活性关系分析。StARTS 可以方便地根据亲和力和选择性对所选 RNA 基序-氨基糖苷类相互作用进行注释。2DCS 选择的相互作用通常具有纳摩尔亲和力,这比氨基糖苷类与细菌 rRNA A 位的治疗靶点模拟物的结合亲和力更高。